KT&G (033780) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Jun, 2026Executive summary
Achieved record-high consolidated revenue of KRW 5.91 trillion for FY24, up 0.8% year-over-year, with operating profit rising 1.5% and net income surging 23.8%.
Q4 revenue grew 8% YoY to KRW 1.5571 trillion; operating profit up 5.3% YoY to KRW 208.5 billion; net income jumped 167.2% YoY to KRW 301.7 billion.
Robust performance in Global CC and Next Generation Products (NGP) segments drove topline and profitability improvements.
Enhanced capital efficiency with ROE at 12.2%, up 2.3 percentage points from 2023.
Total shareholder return ratio reached nearly 100% of net income, with KRW 1.1 trillion in cash returns and 8.46 million shares cancelled.
Financial highlights
FY24 consolidated revenue: KRW 5.91 trillion (+0.8% YoY); operating profit: KRW 1.1848 trillion (+1.5% YoY); net income: KRW 1,141.6 billion (+23.8% YoY); EPS: KRW 10,167 (+29.6% YoY).
Q4 revenue: KRW 1.5571 trillion (+8% YoY); operating profit: KRW 208.5 billion (+5.3% YoY); net income: KRW 301.7 billion (+167.2% YoY); EPS: KRW 2,696 (+152.7% YoY).
EBITDA for FY24: KRW 1.4350 trillion (24.3% margin, +1.9% YoY).
Gross profit margin for FY24: 48.0%; operating profit margin: 26.4%; net income margin: 19.3%.
Dividend payout ratio at 52%; annual DPS at KRW 5,400, a record high.
Outlook and guidance
2025 guidance targets 5%-7% revenue growth and 6%-8% operating profit growth YoY.
Shareholder return plans include cash dividends totaling KRW 600 billion and share buyback/cancellation of at least KRW 300 billion.
Targeting a shareholder return ratio of 100%+ and further share cancellation (over 4.5% of outstanding shares).
Focus on global market penetration and core tobacco business to reinforce competitiveness.
Plans to execute over KRW 1.1 trillion in cash returns.
Latest events from KT&G
- Q2 profit jumped on global tobacco gains, but 2024 outlook was cut as HFF and real estate lagged.033780
Q2 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Q1 2025 revenue up 15.4% YoY, strong profit growth, and ongoing share buybacks.033780
Q1 202524 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record revenue and profit, net income up 73.4%, guidance raised, global expansion planned.033780
Q3 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025